BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33051287)

  • 1. Pitfalls in the diagnosis of lentigo maligna and lentigo maligna melanoma, facts and an opinion.
    Sina N; Saeed-Kamil Z; Ghazarian D
    J Clin Pathol; 2021 Jan; 74(1):7-9. PubMed ID: 33051287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions.
    Moreno A; Manrique-Silva E; Virós A; Requena C; Sanmartín O; Traves V; Nagore E
    JAMA Dermatol; 2019 Jul; 155(7):782-788. PubMed ID: 31066867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentigo maligna and lentigo maligna melanoma.
    Johr RH; Stolz W
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512. PubMed ID: 9308580
    [No Abstract]   [Full Text] [Related]  

  • 4. Lentigo maligna and lentigo maligna melanoma.
    Cohen LM
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
    [No Abstract]   [Full Text] [Related]  

  • 5. Lentigo maligna and lentigo maligna melanoma.
    Cohen LM
    J Am Acad Dermatol; 1995 Dec; 33(6):923-36; quiz 937-40. PubMed ID: 7490362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.
    Zoutendijk J; Tio D; Koljenovic S; van den Bos RR
    Br J Dermatol; 2019 Aug; 181(2):383-384. PubMed ID: 30716164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
    Ren M; Kong YY; Shen XX; Cai X; Kong JC
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.
    Yélamos O; Cordova M; Blank N; Kose K; Dusza SW; Lee E; Rajadhyaksha M; Nehal KS; Rossi AM
    JAMA Dermatol; 2017 Dec; 153(12):1278-1284. PubMed ID: 29049429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.
    King R; Page RN; Googe PB; Mihm MC
    Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
    Ahlgrimm-Siess V; Massone C; Scope A; Fink-Puches R; Richtig E; Wolf IH; Koller S; Gerger A; Smolle J; Hofmann-Wellenhof R
    Br J Dermatol; 2009 Dec; 161(6):1307-16. PubMed ID: 19566662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical lentiginous junctional naevi of the elderly and melanoma.
    Kossard S
    Australas J Dermatol; 2002 May; 43(2):93-101. PubMed ID: 11982564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study.
    Peruilh-Bagolini L; Apalla Z; González-Cuevas R; Lallas K; Papageorgiou C; Bobos M; Manoli SM; Gkentsidi T; Spyridis I; Lazaridou E; Sotiriou E; Vakirlis E; Ioannides D; Lallas A
    J Am Acad Dermatol; 2020 Jul; 83(1):269-271. PubMed ID: 32199898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant lentigo].
    Knudsen EA; Osterlind AL
    Ugeskr Laeger; 1994 Jul; 156(29):4221-3. PubMed ID: 8066918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic predictors of invasion in partially biopsied lentigo maligna melanoma.
    Aouidad I; Fargeas C; Romero P; Sei JF; Chaussade V; Beauchet A; Clerici T; Zimmermann U; Saiag P; Funck-Brentano E
    J Am Acad Dermatol; 2019 Apr; 80(4):1150-1152. PubMed ID: 30879481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lentigo maligna: a diagnostic and therapeutic challenge].
    Alcalay J
    Harefuah; 2014 May; 153(5):259-60, 306, 305. PubMed ID: 25112116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma.
    Tio D; Willemsen M; Krebbers G; Kasiem FR; Hoekzema R; van Doorn R; Bekkenk MW; Luiten RM
    Am J Dermatopathol; 2020 Aug; 42(8):625-627. PubMed ID: 32701706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
    Magro CM; Yang SE; Zippin JH; Zembowicz A
    Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.